<VariationArchive VariationID="1804984" VariationName="NM_003042.4(SLC6A1):c.1607del (p.Val536fs)" VariationType="Deletion" Accession="VCV001804984" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2022-12-24" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1861999" VariationID="1804984">
      <GeneList>
        <Gene Symbol="SLC6A1" FullName="solute carrier family 6 member 1" GeneID="6529" HGNC_ID="HGNC:11042" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="10992748" stop="11039247" display_start="10992748" display_stop="11039247" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="11034419" stop="11080934" display_start="11034419" display_stop="11080934" Strand="+" />
          </Location>
          <OMIM>137165</OMIM>
          <Haploinsufficiency last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003042.4(SLC6A1):c.1607del (p.Val536fs)</Name>
      <CanonicalSPDI>NC_000003.12:11034609:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="11034610" stop="11034610" display_start="11034610" display_stop="11034610" variantLength="1" positionVCF="11034609" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="11076296" stop="11076296" display_start="11076296" display_stop="11076296" variantLength="1" positionVCF="11076295" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>V358fs</ProteinChange>
      <ProteinChange>V416fs</ProteinChange>
      <ProteinChange>V536fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.11076296del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.11076296del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.11034610del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.11034610del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_053003.1" sequenceAccession="NG_053003" sequenceVersion="1" change="g.46882del">
            <Expression>NG_053003.1:g.46882del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348250.2" sequenceAccession="NM_001348250" sequenceVersion="2" change="c.1607del">
            <Expression>NM_001348250.2:c.1607del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001335179.1" sequenceAccession="NP_001335179" sequenceVersion="1" change="p.Val536fs">
            <Expression>NP_001335179.1:p.Val536fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348251.2" sequenceAccession="NM_001348251" sequenceVersion="2" change="c.1247del">
            <Expression>NM_001348251.2:c.1247del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001335180.1" sequenceAccession="NP_001335180" sequenceVersion="1" change="p.Val416fs">
            <Expression>NP_001335180.1:p.Val416fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348252.2" sequenceAccession="NM_001348252" sequenceVersion="2" change="c.1073del">
            <Expression>NM_001348252.2:c.1073del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001335181.1" sequenceAccession="NP_001335181" sequenceVersion="1" change="p.Val358fs">
            <Expression>NP_001335181.1:p.Val358fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348253.2" sequenceAccession="NM_001348253" sequenceVersion="2" change="c.1073del">
            <Expression>NM_001348253.2:c.1073del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001335182.1" sequenceAccession="NP_001335182" sequenceVersion="1" change="p.Val358fs">
            <Expression>NP_001335182.1:p.Val358fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003042.4" sequenceAccession="NM_003042" sequenceVersion="4" change="c.1607del" MANESelect="true">
            <Expression>NM_003042.4:c.1607del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003033.3" sequenceAccession="NP_003033" sequenceVersion="3" change="p.Val536fs">
            <Expression>NP_003033.3:p.Val536fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003042.4(SLC6A1):c.1607del (p.Val536fs) AND Myoclonic-astatic epilepsy" Accession="RCV003444276" Version="1">
        <ClassifiedConditionList TraitSetID="72209">
          <ClassifiedCondition DB="MedGen" ID="C0393702">Myoclonic-astatic epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-05-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003042.4(SLC6A1):c.1607del (p.Val536fs) AND Myoclonic-atonic epilepsy" Accession="RCV003763175" Version="1">
        <ClassifiedConditionList TraitSetID="92306">
          <ClassifiedCondition DB="MedGen" ID="CN231318">Myoclonic-atonic epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-14" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-12-24" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25865495</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="72209" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="29076" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myoclonic atonic seizures</ElementValue>
                <XRef ID="HP:0011170" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Generalized myoclonic-atonic seizure</ElementValue>
                <XRef ID="HP:0011170" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Myoclonic-astatic epilepsy</ElementValue>
                <XRef ID="MONDO:0016025" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2169" />
                <XRef ID="2169" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1942" DB="Orphanet" />
              <XRef ID="C0393702" DB="MedGen" />
              <XRef ID="MONDO:0016025" DB="MONDO" />
              <XRef Type="primary" ID="HP:0011170" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="92306" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33535" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Myoclonic-atonic epilepsy</ElementValue>
                <XRef ID="MONDO:0014633" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MAE</ElementValue>
                <XRef Type="MIM" ID="616421" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16108" />
                <XRef ID="16108" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36780407</ID>
                <ID Source="BookShelf">NBK589173</ID>
              </Citation>
              <XRef ID="1942" DB="Orphanet" />
              <XRef ID="CN231318" DB="MedGen" />
              <XRef ID="MONDO:0014633" DB="MONDO" />
              <XRef Type="MIM" ID="616421" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5412879" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_003042_3_SLC6A1_c_1607delT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002767425" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with myoclonic-atonic epilepsy (MIM#616421). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. More than ten others have been reported in affected individuals (DECIPHER, ClinVar). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed) (by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_7015</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003042.3:c.1607delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616421" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8200110" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="17905141|MedGen:C4085238" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004410568" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25865495</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with SLC6A1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val536Glyfs*4) in the SLC6A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC6A1 are known to be pathogenic (PMID: 25865495).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.11076296del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4085238" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5412879" TraitType="Disease" MappingType="XRef" MappingValue="616421" MappingRef="OMIM">
        <MedGen CUI="CN231318" Name="Myoclonic-atonic epilepsy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8200110" TraitType="Disease" MappingType="XRef" MappingValue="C4085238" MappingRef="MedGen">
        <MedGen CUI="CN231318" Name="Myoclonic-atonic epilepsy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

